Bio-Rad Laboratories, Inc. (BIO) is in Healthcare, Medical Devices, based in United States, listed on NYSE. Market cap 9.64B USD. 52-week range 236.73 to 396.23 USD. Trailing P/E 45.7. Data as of 2026-10-09.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids ...